DK1267866T3 - Behandling af respirationssygdomme - Google Patents

Behandling af respirationssygdomme

Info

Publication number: DK1267866T3
Authority: DK; Denmark
Prior art keywords: treatment; respiratory diseases; glycopyrrolate; dry powder; formulation
Prior art date: 2000-04-07

Application number

DK01966751T

Other languages

English (en)

Other versions

DK1267866T4 (da

Inventor

Robin Mark Bannister

Andrew John Richards

Julian Clive Gilbert

David A Morton

John Staniforth

Original Assignee

Arakis Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-07

Filing date

2001-04-09

Publication date

2006-10-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9889490&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1267866(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-04-09 Application filed by Arakis Ltd filed Critical Arakis Ltd

2006-10-23 Application granted granted Critical

2006-10-23 Publication of DK1267866T3 publication Critical patent/DK1267866T3/da

2016-10-03 Publication of DK1267866T4 publication Critical patent/DK1267866T4/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Detergent Compositions (AREA)
Steroid Compounds (AREA)

DK01966751.8T 2000-04-07 2001-04-09 Behandling af åndedrætssygdomme DK1267866T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0008660.3A GB0008660D0 (en)	2000-04-07	2000-04-07	The treatment of respiratory diseases
PCT/GB2001/001606 WO2001076575A2 (en)	2000-04-07	2001-04-09	The treatment of respiratory diseases

Publications (2)

Publication Number	Publication Date
DK1267866T3 true DK1267866T3 (da)	2006-10-23
DK1267866T4 DK1267866T4 (da)	2016-10-03

Family

ID=9889490

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01966751.8T DK1267866T4 (da)	2000-04-07	2001-04-09	Behandling af åndedrætssygdomme

Country Status (25)

Country	Link
US (3)	US7229607B2 (da)
EP (3)	EP1449528B1 (da)
JP (1)	JP5042426B2 (da)
CN (3)	CN101181263B (da)
AT (1)	ATE330585T2 (da)
AU (2)	AU2004242450B2 (da)
BE (1)	BE2013C023I2 (da)
BR (1)	BR0109875A (da)
CA (1)	CA2405705C (da)
CY (1)	CY1105120T1 (da)
DE (1)	DE60120936T3 (da)
DK (1)	DK1267866T4 (da)
ES (2)	ES2266242T5 (da)
GB (1)	GB0008660D0 (da)
HK (1)	HK1050846B (da)
HU (2)	HU230958B1 (da)
IL (2)	IL151791A0 (da)
LU (2)	LU92166I2 (da)
MX (1)	MXPA02009718A (da)
NO (3)	NO336142B1 (da)
NZ (2)	NZ535284A (da)
PL (1)	PL364024A1 (da)
PT (1)	PT1267866E (da)
WO (1)	WO2001076575A2 (da)
ZA (1)	ZA200207420B (da)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0008660D0 (en) *	2000-04-07	2000-05-31	Arakis Ltd	The treatment of respiratory diseases
DE60140268D1 (de)	2000-11-30	2009-12-03	Vectura Ltd	Partikel zur verwendung in einer pharmazeutischen zusammensetzung
PT1920763E (pt)	2000-11-30	2014-06-25	Vectura Ltd	Composições farmacêuticas para inalação
CA2341952A1 (en)	2001-03-23	2002-09-23	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
US20050130990A1 (en) *	2001-03-23	2005-06-16	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
JP4510384B2 (ja)	2001-05-23	2010-07-21	田辺三菱製薬株式会社	骨折治癒促進用組成物
EP1389467B1 (en)	2001-05-23	2013-07-03	Mitsubishi Tanabe Pharma Corporation	Therapeutic composition for the regenerative treatment of cartilage diseases
KR100947409B1 (ko) *	2002-03-01	2010-03-12	키에시 파르마슈티시 엣스. 피. 에이.	포모테롤 초미세 조성물
US8557804B2 (en)	2002-03-25	2013-10-15	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
US8039459B2 (en) *	2004-07-15	2011-10-18	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
US20040121003A1 (en) *	2002-12-19	2004-06-24	Acusphere, Inc.	Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US7419801B2 (en) *	2003-08-08	2008-09-02	Arriva Pharmaceuticals, Inc.	Methods of protein production in yeast
GB0327723D0 (en) *	2003-09-15	2003-12-31	Vectura Ltd	Pharmaceutical compositions
JP2007511539A (ja) *	2003-11-14	2007-05-10	バクスター・インターナショナル・インコーポレイテッド	α１−抗トリプシン組成物およびこのような組成物を用いた処置方法
JP5524442B2 (ja) *	2004-02-06	2014-06-18	メダファーマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	呼吸器疾患の治療のための、抗コリン作用薬及びβ−模倣薬の新規併用薬
PT1713473E (pt)	2004-02-06	2013-05-13	Meda Pharma Gmbh & Co Kg	Combinação de anticolinérgicos e glucocorticóides para o tratamento a longo prazo de asma e copd
CN101518532A (zh) *	2004-02-06	2009-09-02	Meda制药有限及两合公司	用于呼吸道疾病治疗的抗胆碱能药和4型磷酸二酯酶抑制剂的组合
JP2007520509A (ja) *	2004-02-06	2007-07-26	メダファーマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	抗コリン薬による、又は抗ヒスタミン薬、ホスホジエステラーゼ４、又はコルチコステロイドとの組み合わせによる鼻炎治療薬
US20070185067A1 (en) *	2004-02-27	2007-08-09	Altana Pharma Ag	Ciclesonide and glycopyrronium combination
EP1737499A4 (en) *	2004-03-09	2009-07-22	Arriva Pharmaceuticals Inc	TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE BY INHALATION OF LOW DOSES OF A PROTEASE HEMMER
GB0409703D0 (en) *	2004-04-30	2004-06-02	Vectura Ltd	Pharmaceutical compositions
GB0410399D0 (en) *	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
GB0410398D0 (en) *	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
CA2568834A1 (en) *	2004-06-29	2006-01-12	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising steroids and an anticholinergic
EP1616567A1 (en) *	2004-07-16	2006-01-18	Boehringer Ingelheim Pharma GmbH & Co.KG	Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts
WO2006026502A1 (en)	2004-08-27	2006-03-09	The Dow Chemical Company	Enhanced delivery of drug compositions to treat life threatening infections
US20070105768A1 (en) *	2004-11-10	2007-05-10	Rajiv Nayar	Dry recombinant human alpha 1-antitrypsin formulation
GB0425758D0 (en) *	2004-11-23	2004-12-22	Vectura Ltd	Preparation of pharmaceutical compositions
JP5288791B2 (ja) *	2005-01-28	2013-09-11	武田薬品工業株式会社	難水溶性物質含有微細化組成物
CN101128196B (zh)	2005-03-16	2013-01-02	Meda制药有限及两合公司	用于治疗呼吸系统疾病的抗胆碱能药和白三烯受体拮抗剂的组合
JP2008534480A (ja) *	2005-03-24	2008-08-28	ソーセイアールアンドディリミテッド	グリコピロニウム塩およびそれらの治療的使用
CA2631492A1 (en) *	2005-12-15	2007-06-21	Acusphere, Inc.	Processes for making particle-based pharmaceutical formulations for oral administration
NZ568349A (en)	2005-12-21	2011-05-27	Meda Pharma Gmbh & Co Kg	Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases
GB2434098A (en) *	2005-12-23	2007-07-18	Novartis Ag	Process for the preparation of an inhalable dry powder formulation
WO2007109142A2 (en) *	2006-03-17	2007-09-27	Oregon Health & Science University	M3 muscarinic receptor antagonists for treating tumors
GB0613161D0 (en)	2006-06-30	2006-08-09	Novartis Ag	Organic Compounds
EP2229148B1 (en) *	2007-12-13	2014-03-05	Novartis AG	Process for preparing a particulate and crystalline drug substance
KR20100099281A (ko) *	2007-12-13	2010-09-10	노파르티스 아게	유기 화합물
NZ587561A (en) *	2008-02-26	2012-10-26	Elevation Pharmaceuticals Inc	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations (an muscarinic antagnoist)
US20100055045A1 (en) *	2008-02-26	2010-03-04	William Gerhart	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
US11116721B2 (en)	2009-02-26	2021-09-14	Glaxo Group Limited	Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
TWI792140B (zh)	2009-05-29	2023-02-11	美商沛爾醫療股份有限公司	用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
GB0921075D0 (en)	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
WO2011076840A2 (en)	2009-12-23	2011-06-30	Chiesi Farmaceutici S.P.A.	Aerosol formulation for copd
PH12012501066A1 (en)	2009-12-23	2016-03-02	Chiesi Farm Spa	Combination therapy for copd
EP2515854B1 (en)	2009-12-23	2014-03-19	Chiesi Farmaceutici S.p.A.	Aerosol formualtion for COPD
KR101738712B1 (ko)	2009-12-23	2017-05-22	키에시 파르마슈티시 엣스. 피. 에이.	Ｃｏｐｄ용 조합요법
RU2017144619A (ru) *	2010-09-29	2019-02-20	Пулмэтрикс, Инк.	Катионы одновалентных металлов сухих порошков для ингаляций
JOP20120023B1 (ar) *	2011-02-04	2022-03-14	Novartis Ag	صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
RS58456B1 (sr)	2011-08-01	2019-04-30	Univ Monash	Postupak i formulacije za inhalaciju
US20150136130A1 (en)	2012-02-29	2015-05-21	Pulmatrix, Inc.	Inhalable dry powders
TR201902687T4 (tr)	2013-03-15	2019-03-21	Pearl Therapeutics Inc	İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler.
CA2907566C (en)	2013-04-01	2023-08-22	Pulmatrix, Inc.	Tiotropium dry powders
US9393202B2 (en)	2013-04-26	2016-07-19	Chiesi Farmaceutici S.P.A	Particle size reduction of an antimuscarinic compound
EP3082708B1 (en) *	2013-12-17	2019-04-03	Merck Sharp & Dohme Corp.	Media milling process for the manufacture of active pharmaceutical ingredients in propellants
JP6563950B2 (ja)	2013-12-30	2019-08-21	シエシーファルマセウティチィソシエタペルアチオニ	グリコピロニウム臭化物およびホルモテロールの組合せの安定な加圧エアゾール溶液組成物
MX373939B (es)	2014-09-09	2020-07-10	Vectura Ltd	Formulacion que comprende glicopirrolato, metodo y aparato.
DK3193835T3 (da) *	2014-09-15	2018-05-07	Verona Pharma Plc	Flydende inhalationsformulering, der omfatter RPL554
MA41378A (fr) *	2015-01-20	2017-11-28	Teva Branded Pharmaceutical Prod R & D Inc	Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol
US20160310410A1 (en)	2015-04-24	2016-10-27	Glenmark Specialty S.A.	Pharmaceutical compositions comprising arformoterol and glycopyrronium
AU2016279798B2 (en) *	2015-06-15	2021-07-08	Qaam Pharmaceuticals, Llc	Glycopyrronium fatty acid salts and methods of making same
US9925168B2 (en) *	2016-01-22	2018-03-27	Chiesi Farmaceutici S.P.A.	Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation
US10098837B2 (en)	2016-07-28	2018-10-16	Chiesi Farmaceutici S.P.A.	Combination therapy for COPD
MX2022004781A (es)	2019-12-02	2022-05-16	Chiesi Farm Spa	Lata de acero inoxidable para inhaladores dosificadores presurizados.

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3400197A (en)	1965-01-26	1968-09-03	Robins Co Inc A H	Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US5376386A (en) *	1990-01-24	1994-12-27	British Technology Group Limited	Aerosol carriers
US5849263A (en) *	1993-03-30	1998-12-15	Charlotte-Mecklenburg Hospital Authority	Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
TW402506B (en) *	1993-06-24	2000-08-21	Astra Ab	Therapeutic preparation for inhalation
DE4425255A1 (de) *	1994-07-16	1996-01-18	Asta Medica Ag	Formulierung zur inhalativen Applikation
AR002009A1 (es) *	1994-12-22	1998-01-07	Astra Ab	Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
US5612053A (en) *	1995-04-07	1997-03-18	Edward Mendell Co., Inc.	Controlled release insufflation carrier for medicaments
US5690374A (en) *	1996-04-19	1997-11-25	Nor-Easter Enterprises, Inc.	Shock-absorbing tool handle
US6613795B2 (en)	1996-11-11	2003-09-02	Christian Noe	Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
DE59709927D1 (de)	1996-11-11	2003-05-28	Noe Christian	Verwendung eines pharmazeutisch geeigneten Salzes von (3R,2'R)-3-[(Cyclopentyl-hydroxyphenylacetyl)oxy]-1,1-dimethyl-pyrrolidinium zur Herstellung eines Arzneimittels
EP0954282B1 (en) *	1997-01-16	2005-01-19	Massachusetts Institute Of Technology	Preparation of particles for inhalation
SE9700133D0 (sv) *	1997-01-20	1997-01-20	Astra Ab	New formulation
US6461591B1 (en) *	1997-02-05	2002-10-08	Jago Research Ag	Medical aerosol formulations
US6495167B2 (en) *	1997-03-20	2002-12-17	Schering Corporation	Preparation of powder agglomerates
DE59911149D1 (de) *	1998-07-24	2004-12-30	Jago Res Ag Muttenz	Medizinische aerosolformulierungen
JP4672143B2 (ja) *	1998-08-04	2011-04-20	ヤゴテックアーゲー	医薬用エーロゾル製剤
CA2347856C (en) *	1998-11-13	2009-02-17	Jago Research Ag	Dry powder for inhalation
US6406745B1 (en) *	1999-06-07	2002-06-18	Nanosphere, Inc.	Methods for coating particles and particles produced thereby
AU7389300A (en) *	1999-08-02	2001-02-19	First Horizon Pharmaceutical Corporation	Methods of administration of glycopyrrolate compositions
GB0008660D0 (en)	2000-04-07	2000-05-31	Arakis Ltd	The treatment of respiratory diseases
US6758795B2 (en) *	2000-08-22	2004-07-06	Stephen Barber	Adjustable water-fillable exercise weights
GB0029903D0 (en) *	2000-12-07	2001-01-24	Arakis Ltd	Use of anti-muscarinic agents
GB0410399D0 (en) *	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
GB0410398D0 (en) *	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
TWI509631B (zh)	2011-02-25	2015-11-21	漢高智慧財產控股公司	用於電子裝置之可燒結銀薄片黏著劑

2000
- 2000-04-07 GB GBGB0008660.3A patent/GB0008660D0/en not_active Ceased
2001
- 2001-04-09 ES ES01966751.8T patent/ES2266242T5/es not_active Expired - Lifetime
- 2001-04-09 EP EP04011047.0A patent/EP1449528B1/en not_active Expired - Lifetime
- 2001-04-09 NZ NZ535284A patent/NZ535284A/xx not_active IP Right Cessation
- 2001-04-09 PL PL01364024A patent/PL364024A1/xx not_active Application Discontinuation
- 2001-04-09 BR BR0109875-6A patent/BR0109875A/pt not_active Application Discontinuation
- 2001-04-09 CN CN2007101471670A patent/CN101181263B/zh not_active Expired - Lifetime
- 2001-04-09 WO PCT/GB2001/001606 patent/WO2001076575A2/en not_active Ceased
- 2001-04-09 ES ES04011047.0T patent/ES2687751T3/es not_active Expired - Lifetime
- 2001-04-09 CN CNA200510076362XA patent/CN1720995A/zh active Pending
- 2001-04-09 EP EP01966751.8A patent/EP1267866B2/en not_active Expired - Lifetime
- 2001-04-09 AT AT01966751T patent/ATE330585T2/de active
- 2001-04-09 DE DE60120936.2T patent/DE60120936T3/de not_active Expired - Lifetime
- 2001-04-09 DK DK01966751.8T patent/DK1267866T4/da active
- 2001-04-09 HU HU0301518A patent/HU230958B1/hu active Protection Beyond IP Right Term
- 2001-04-09 CA CA2405705A patent/CA2405705C/en not_active Expired - Lifetime
- 2001-04-09 CN CNB018075584A patent/CN1292745C/zh not_active Expired - Lifetime
- 2001-04-09 EP EP10153877A patent/EP2193791A1/en not_active Withdrawn
- 2001-04-09 IL IL15179101A patent/IL151791A0/xx unknown
- 2001-04-09 HK HK03101991.4A patent/HK1050846B/en unknown
- 2001-04-09 JP JP2001574093A patent/JP5042426B2/ja not_active Expired - Lifetime
- 2001-04-09 NZ NZ521476A patent/NZ521476A/en not_active IP Right Cessation
- 2001-04-09 PT PT01966751T patent/PT1267866E/pt unknown
- 2001-04-09 MX MXPA02009718A patent/MXPA02009718A/es active IP Right Grant
2002
- 2002-09-16 ZA ZA200207420A patent/ZA200207420B/en unknown
- 2002-09-18 IL IL151791A patent/IL151791A/en active IP Right Grant
- 2002-10-01 NO NO20024708A patent/NO336142B1/no not_active IP Right Cessation
- 2002-10-07 US US10/266,717 patent/US7229607B2/en not_active Expired - Lifetime
2004
- 2004-08-24 US US10/926,196 patent/US7368104B2/en not_active Expired - Lifetime
- 2004-12-22 AU AU2004242450A patent/AU2004242450B2/en not_active Expired
2006
- 2006-07-31 CY CY20061101079T patent/CY1105120T1/el unknown
2008
- 2008-03-14 US US12/048,812 patent/US8029768B2/en not_active Expired - Lifetime
2010
- 2010-02-23 AU AU2010200660A patent/AU2010200660B2/en active Active
2013
- 2013-03-13 LU LU92166C patent/LU92166I2/fr unknown
- 2013-03-26 BE BE2013C023C patent/BE2013C023I2/fr unknown
2014
- 2014-03-07 LU LU92393C patent/LU92393I2/xx unknown
2015
- 2015-11-25 NO NO2015025C patent/NO2015025I1/no not_active Application Discontinuation
- 2015-11-25 NO NO2015024C patent/NO2015024I2/no not_active IP Right Cessation
2019
- 2019-12-23 HU HUS1900056C patent/HUS1900056I1/hu unknown

Also Published As

Publication number	Publication date
MXPA02009718A (es)	2003-05-27
DK1267866T4 (da)	2016-10-03
IL151791A0 (en)	2003-04-10
NO336142B1 (no)	2015-05-26
ES2266242T3 (es)	2007-03-01
US20080220073A1 (en)	2008-09-11
EP1267866B2 (en)	2016-07-20
DE60120936D1 (de)	2006-08-03
NO20024708L (no)	2002-10-24
EP1267866B1 (en)	2006-06-21
DE60120936T3 (de)	2016-11-17
CN1422154A (zh)	2003-06-04
GB0008660D0 (en)	2000-05-31
AU776913B2 (en)	2004-09-23
CY1105120T1 (el)	2010-03-03
ZA200207420B (en)	2003-09-16
LU92166I2 (fr)	2014-03-13
ATE330585T2 (de)	2006-07-15
EP2193791A1 (en)	2010-06-09
EP1267866A2 (en)	2003-01-02
HK1050846A1 (en)	2003-07-11
AU8930601A (en)	2001-10-23
NZ535284A (en)	2006-04-28
CN1720995A (zh)	2006-01-18
WO2001076575A3 (en)	2002-03-28
HUP0301518A2 (hu)	2003-08-28
US20030068280A1 (en)	2003-04-10
NO2015025I1 (no)	2015-12-07
LU92393I2 (fr)	2015-11-02
US7229607B2 (en)	2007-06-12
US20050019271A1 (en)	2005-01-27
HU230958B1 (hu)	2019-06-28
CA2405705C (en)	2011-06-07
BR0109875A (pt)	2004-07-20
ES2266242T5 (es)	2016-10-04
EP1449528B1 (en)	2018-08-08
AU2004242450A1 (en)	2005-01-20
IL151791A (en)	2015-05-31
CN101181263A (zh)	2008-05-21
AU2010200660A1 (en)	2010-03-11
NO2015024I1 (no)	2015-11-25
EP1449528A1 (en)	2004-08-25
HK1050846B (en)	2007-01-26
PT1267866E (pt)	2006-10-31
AU2004242450B2 (en)	2010-06-03
HUS1900056I1 (hu)	2020-02-28
CA2405705A1 (en)	2001-10-18
DE60120936T2 (de)	2006-11-02
NO2015024I2 (no)	2015-11-25
AU2010200660B2 (en)	2012-04-19
NO20024708D0 (no)	2002-10-01
JP5042426B2 (ja)	2012-10-03
CN101181263B (zh)	2011-07-06
WO2001076575A2 (en)	2001-10-18
PL364024A1 (en)	2004-11-29
US8029768B2 (en)	2011-10-04
NZ521476A (en)	2004-10-29
ES2687751T3 (es)	2018-10-29
CN1292745C (zh)	2007-01-03
JP2003530344A (ja)	2003-10-14
BE2013C023I2 (da)	2020-06-24
US7368104B2 (en)	2008-05-06

Publication	Publication Date	Title
DK1267866T3 (da)	2006-10-23	Behandling af respirationssygdomme
IL167900A (en)	2013-06-27	Use of betamimetics to prepare a medical preparation for the treatment of chronic obstructive pulmonary disease
MXPA02011311A (es)	2003-04-25	Composicion novedosa.
CL2003002746A1 (es)	2005-02-11	Compuesto derivado de piridazin-3(2h)-ona sustituida en las posiciones 4,5,6; procedimiento de preparacion de dicho compuesto; compuesto intermediario; composicion farmaceutica; y el uso del compuesto para el tratamiento del asma, enfermedad pulmonar
ATE330589T1 (de)	2006-07-15	Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
CY1111693T1 (el)	2015-10-07	Αντιιικοι παραγοντες
EA200200551A1 (ru)	2002-12-26	Новые содержащие тиотропий порошки для ингаляции
BR0015908A (pt)	2002-08-06	Emprego de compostos org nicos no tratamento de doenças
DK1341542T3 (da)	2007-09-03	Indanylderivater til behandling af luftvejssygdomme
YU71901A (sh)	2005-07-19	NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
BRPI0409109A (pt)	2006-03-28	novos compostos
NO20071577L (no)	2007-05-02	Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
BR9914360A (pt)	2001-11-20	N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5
NO20065061L (no)	2006-11-07	Benzoksazin for behandling av sykdommer i luftveiene
ATE479433T1 (de)	2010-09-15	Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
MXPA03011702A (es)	2004-03-19	Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
MY145166A (en)	2011-12-30	Novel tiotropium salts, process for the preparation and pharmaceutical compositions thereof
PE20011004A1 (es)	2001-09-28	Composicion de liberacion controlada de un inhibidor de fosfodiesterasa 4
EA200300152A1 (ru)	2003-08-28	Фармацевтический препарат сальметерола и пропионата флутиказона
UY30935A1 (es)	2008-09-30	Combinacion:-antagonista del receptor de quimioquina 1 (ccr1) -agonista del receptor de glucocorticoides- opcionalmente agonista b(beta)2, -composicion farmacéutica conteniéndola -aplicaciones.
BRPI0417946A (pt)	2007-04-17	composto, métodos para o tratamento ou a profilaxia de uma doença ou condição, e de distúrbios, e para a indução da cessação do hábito de fumar, composição farmacêutica, e, uso de um composto
SG137859A1 (en)	2007-12-28	Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
HUP0102388A3 (en)	2004-11-29	Use of diazepinoindole derivatives for the preparation of pharmaceutical composition treating chronic obstructive pulmonary disease
HRP20100208T8 (hr)	2010-06-30	Postupak liječenja akutnog rinosinusitisa
NO20081483L (no)	2008-05-16	Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma